Palatin Technologies Showcases Promising Phase 2b Results for Diabetic Kidney Disease Treatment Palatin Technologies presents impressive Phase 2b study results at the National Kidney Foundation Spring Meeting, highlighting improvements in diabetic kidney disease management.

Palatin Technologies Showcases Promising Phase 2b Results for Diabetic Kidney Disease Treatment #United_States #Boston #Palatin_Technologies #Diabetic_Nephropathy #Melanocortin_Agonist

Palatin Technologies Reports Successful Phase IIb BREAKOUT Study for Type 2 Diabetic Nephropathy Treatment Palatin Technologies has announced promising results from its Phase IIb BREAKOUT study, focusing on the treatment of Type 2 diabetic nephropathy using bremelanotide. The findings highlight significant kidney function benefits.

Palatin Technologies Reports Successful Phase IIb BREAKOUT Study for Type 2 Diabetic Nephropathy Treatment #United_States #Palatin_Technologies #Cranbury #Bremelanotide #Diabetic_Nephropathy